Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response

A major limiting factor retarding the clinical success of dendritic cell (DC)-based genetic immunizations (DNA vaccination) is the scarcity of biologically safe and effective carrier systems for targeting the antigen-encoded DNA vaccines to DCs under in vivo settings. Herein, we report on a potent,...

Descripción completa

Detalles Bibliográficos
Autores principales: Garu, Arup, Moku, Gopikrishna, Gulla, Suresh Kumar, Chaudhuri, Arabinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817821/
https://www.ncbi.nlm.nih.gov/pubmed/26666450
http://dx.doi.org/10.1038/mt.2015.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817821/
https://www.ncbi.nlm.nih.gov/pubmed/26666450
http://dx.doi.org/10.1038/mt.2015.215

Ejemplares similares